Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 14,223 | 12,234 | 14,481 | 11,873 | 11,980 |
| Operating Income | -14,223 | -12,234 | -14,481 | -11,873 | -11,980 |
| Interest Expense | 0 | 9 | -3 | -224 | 0 |
| Other Income | -1,169 | -75 | -1,890 | 2,248 | -1,101 |
| Pre-tax Income | -15,393 | -12,318 | -16,368 | -9,400 | -13,081 |
| Net Income Continuous | -15,393 | -12,318 | -16,368 | -9,400 | -13,081 |
| Net Income | $-15,393 | $-12,318 | $-16,368 | $-9,400 | $-13,081 |
| EPS Basic Total Ops | -14.41 | -11.60 | -15.60 | -9.00 | 160.80 |
| EPS Basic Continuous Ops | -14.53 | -11.63 | -15.51 | -8.93 | 160.49 |
| EPS Diluted Total Ops | -14.41 | -11.60 | -15.60 | -9.00 | 160.80 |
| EPS Diluted Continuous Ops | -14.53 | -11.63 | -15.51 | -8.93 | 160.49 |
| EBITDA(a) | $-14,167 | $-12,178 | $-14,433 | $-11,805 | $-11,928 |